| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d78cd2835221849f6a74e6349185819 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04 |
| filingDate |
1983-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bf3b2264827921143bdeb7f4c214447
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12438527ca22beec1b9871ab8422f3d0 |
| publicationDate |
1984-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DD-209817-A5 |
| titleOfInvention |
Process for the preparation of quinoline derivatives |
| abstract |
The invention relates to a process for the preparation of quinoline derivatives for use as medicaments. The aim of the invention is to provide novel compounds having activity as 5-hydroxytryptamine antagonists. According to the invention quinoline derivatives of the general formula are prepared wherein A is the radical (CH deep 2) deep) 2- which may optionally be substituted by one or two alkyl radicals having 1 to 2 carbon atoms: Q is an oxygen or sulfur atom; R 0 is alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or cyclopropyl; R 1 is a defined alkyl radical having 3 to 4 carbon atoms is a phenyl radical which may optionally carry a defined substituent, a defined Hetroarylrest mi 5 or 6 ring atoms; or R 2 and R 3 are hydrogen or an alkyl radical having 1 to 2 carbon atoms; and their pharmaceutically acceptable acid addition salts. |
| priorityDate |
1982-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |